ROHSTOFF INTERNATIONAL

15:34 | 18.12.2017
CSE: 2017-1216 – New Listing – Pivot Pharmaceuticals Inc. (PVOT)

TORONTO, ONTARIO–(Marketwired – Dec. 18, 2017) –

The common shares of Pivot Pharmaceuticals Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Pivot Pharmaceuticals Inc. is an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. (“PGS” or “Pivot Green Stream”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals.

L’inscription a la cote de CSE des actions ordinaires de Pivot Pharmaceuticals Inc. a ete approuvee.

Les documents d’inscription et de divulgation seront disponibles sur www.thecse.com a la date de negociation.

Pivot Pharmaceuticals Inc. est une societe biopharmaceutique emergente qui se consacre au developpement et a la commercialisation de produits pharmaceutiques therapeutiques et de produits nutraceutiques faisant appel a des technologies novatrices de plateformes de delivrance de medicaments. La division des produits de cannabis medical a propriete exclusive de Pivot, Pivot Green Stream Health Solutions Inc. (“PGS” ou “Pivot Green Stream”), mene des activites de recherche, de developpement et de commercialisation de nutraceutiques et de produits pharmaceutiques a base de cannabinoides.

—————————————————————————-
Issuer/Emetteur: Pivot Pharmaceuticals Inc.
—————————————————————————-
Security Type/Titre: Common Shares/Actions
ordinaires
—————————————————————————-
Symbol(s)/Symbole(s): PVOT
—————————————————————————-
Number of securities issued and outstanding/
Titres emis et en circulation: 82 223 323
—————————————————————————-
Number of Securities reserved for issuance/
Titres reserves pour emission: 13 936 208
—————————————————————————-
CSE Sector/Categorie: Life Sciences/Sciences
biologiques
—————————————————————————-
CUSIP: 72580T 20 2
—————————————————————————-
ISIN: CA 72580T 20 2 0
—————————————————————————-
Boardlot/Quotite: 500
—————————————————————————-
Trading Currency/Monnaie de negociation: CDN$/ $CA
—————————————————————————-
Trading Date/Date du debut des negociations : Le 19 decembre/December 2017
—————————————————————————-
Other Exchanges/Autres marches: N/A
—————————————————————————-
Fiscal Year end /Cloture de l’exercice
financier: January 31/le 31 janvier
—————————————————————————-
Transfer Agent/Agent des transferts: National Issuer Services Ltd.
—————————————————————————-

FOR FURTHER INFORMATION PLEASE CONTACT:
Index Management
Robert Cook
Senior Vice-President Market Development
Robert.Cook@thecse.com
(416) 367-7349

Media Relations
Richard Carleton
CEO
Richard.Carleton@thecse.com
(416) 367-7360


NEWSLETTER

Abonnieren Sie jetzt unseren
aktuellen Newsletter

WIRTSCHAFTSNACHRICHTEN

22:51 Uhr | 15.08.2018
GESAMT-ROUNDUP 3: Türkei ...


22:37 Uhr | 15.08.2018
USA bleiben im Konflikt mit der ...


22:18 Uhr | 15.08.2018
Aktien New York Schluss: Trumps ...


21:51 Uhr | 15.08.2018
Finanzinvestor Cevian will bei ...


21:35 Uhr | 15.08.2018
dpa-AFX Überblick: Ausgewählte ...